| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |